Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Income towards Parent Company (2020 - 2025)

Historic Income towards Parent Company for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$2.8 million.

  • iSpecimen's Income towards Parent Company fell 6534.49% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.3 million, marking a year-over-year decrease of 2674.53%. This contributed to the annual value of -$12.9 million for FY2024, which is 1855.21% down from last year.
  • Latest data reveals that iSpecimen reported Income towards Parent Company of -$2.8 million as of Q3 2025, which was down 6534.49% from -$1.8 million recorded in Q2 2025.
  • iSpecimen's 5-year Income towards Parent Company high stood at -$1.4 million for Q2 2021, and its period low was -$6.0 million during Q4 2024.
  • Moreover, its 5-year median value for Income towards Parent Company was -$2.2 million (2024), whereas its average is -$2.5 million.
  • As far as peak fluctuations go, iSpecimen's Income towards Parent Company plummeted by 70125.11% in 2021, and later surged by 4494.69% in 2025.
  • iSpecimen's Income towards Parent Company (Quarter) stood at -$2.0 million in 2021, then fell by 6.51% to -$2.2 million in 2022, then crashed by 30.96% to -$2.8 million in 2023, then crashed by 111.96% to -$6.0 million in 2024, then surged by 52.79% to -$2.8 million in 2025.
  • Its Income towards Parent Company stands at -$2.8 million for Q3 2025, versus -$1.8 million for Q2 2025 and -$1.6 million for Q1 2025.